Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring

Int J Clin Pharmacol Res. 1991;11(5):231-6.

Abstract

Eleven hypertensive pregnant patients were treated with nifedipine orally 10 mg thrice daily. At steady state, nifedipine concentration, measured by the high-performance liquid chromatographic method, was 4.3 +/- 1.0 ng/ml (mean +/- s.e.m.) in maternal serum in the third trimester of pregnancy. During delivery, the parent drug levels in maternal and umbilical serum and in amniotic fluid were 12.4 +/- 4.0, 8.6 +/- 2.3 and 2.5 +/- 1.2 ng/ml, respectively. Small amounts of nifedipine were found also in urine of the neonates. In breast milk, the nifedipine concentration was 4.1 +/- 0.8 ng/ml on the third day after delivery. The antihypertensive effect of nifedipine did not correlate with the serum drug concentration. The outcome of pregnancy was favourable in all cases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Amniotic Fluid / chemistry*
  • Female
  • Fetal Blood / chemistry*
  • Humans
  • Hypertension / drug therapy
  • Maternal-Fetal Exchange
  • Milk, Human / chemistry*
  • Nifedipine / administration & dosage
  • Nifedipine / pharmacokinetics*
  • Nifedipine / urine
  • Pregnancy
  • Tissue Distribution

Substances

  • Nifedipine